维普期刊资源整合服务平台（V6.5）

67篇 您的检索式：作者名="Blanke C D"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Kontrastmittelsonografie bei B-Bild-morphologisch unklaren Leberraumforderungen – Diagnostische Treffsicherheit im klinischen Alltag (DEGUM-Multicenter – Studie)显示文摘	D Strobel K Seitz W Blank A Schuler C Dietrich A Herbay M Friedrich-Rust G Kunze D Becker U Will W Kratzer F Albert C Pachmann K Dirks H Strunk C Greis T Bernatik	2008	Ultraschall in Med2008，，05：	2
2	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri G D Von Mehren M Blanke C D	2002	N Engl J Med2002，347，7：	1
3	Long-term result from a randomized phase Ⅱtrial of standard versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT显示文摘	Blanke C D Demetri G D von Mehren M	2008	J Clin Oncol2008，26，4：	1
4	Phase Ⅲ randomized,intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase:S0033显示文摘	Blanke C D Rankin C Demetri G D	2008	J Clin Oncol2008，26，4：	1
5	Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty显示文摘	Blank S K McCartney C R Helm K D et a1	2007	Semin Reprod Med2007，25，5：	1
6	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri G D Von Mehren M Blanke C D	2002	N Engl J Med2002，347，7：	1
7	Molecular correlates of imatinib resistance in gastrointestinal stromal tumors显示文摘	Heinrich M C Corless C L Blanke C D	2006	J Clin Oncol2006，24，29：	1
8	Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies显示文摘	Heinrich M C Blanke C D Druker B J	2002	J Clin Oncol2002，20，6：	1
9	Power limit of an endorevrsible Ericsson cycle with regeneration 显示文摘	Blank D A Wu C	1997	Energy Convers Mgmt1997，37，1：	1
10	Finite time power limit for solar-radiant Ericsson engines in space applications 显示文摘	Blank D A Wu C	1998	Appl Thermal Engrg1998，18，12：	1
11	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri G D Von Mehren M Blanke C D	2002	N Engl J Med2002，347，7：	1
12	EUROCarbDB:An open-access platform for glycoinformatics显示文摘	vonder Lieth C W Freire A A Blank D	2011	Glycobiology2011，21，4：	1
13	Efficacy and safety of imatinib mesylate in advanced gastrointesti- nal stromal tumors 显示文摘	Demetri G D Mehren M V Blanke C D	2002	N Engl J Med2002，347，7：	1
14	Efficacy and safety of imatinib mesylate in advanced gastrointestinal strpmal tumors显示文摘	Demetri G D von Mehren M Blanke C D	2002	N Engl J M ed2002，347，7：	1
15	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri G D von Mehren M Blanke C D ei al	2002	N Engl J Med2002，347，7：	1
16	Phase II random- ized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unreseetable or metastatic gastrointes- tinal stromal tumors expressing the kit receptor tyrosine ki- nase: S0033显示文摘	Blanke C D Rankin C Demetri G D	2008	JClinOncol2008，26，4：	1
17	Power Optimization of an Endoreversible Stirling Cycle with Regeneration显示文摘	Blank D A Davis G W Wu C	1994	Energy1994，19，：	1
18	Power Optimization of an Extra- terrestrial, Solar- radiant Stirling Heat Energy显示文摘	Blank D A Wu C	1995	Energy1995，22，：	1
19	Evaluation of the safety and efficacy of an oral molecularly-targeted therapy,STI571,in patient with unresectable or metastatic expressing c-kit显示文摘	Blanks C D von Mehren M Tuveson S	2001	ASCO Proc2001，20，1：	1
20	Efficacy andsafaty of imatinib mesylate in advanced gastrointestinal stromaltumors显示文摘	Demetri G D Von Mehren M Blanke C D	2002	N Engl J Meol2002，347，7：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示